XML 33 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies Segment Information and Signficant Customers (Details) - segment
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Accounting Policies [Abstract]      
Number of operating segments 1    
Entity Wide Revenue Sanofi Percentage 89.00% 53.00% 65.00%
Biologics customer concentration   25.00%  
LXRX Diplomat customer concentration   14.00%  
Entity Wide Revenue Ipsen Percentage     18.00%